RecruitingPhase 3NCT04574089

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

Medical Ethics Committee of Peking University Shenzhen Hospital


Sponsor

Peking University Shenzhen Hospital

Enrollment

50 participants

Start Date

May 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Inclusion Criteria4

  • Aerobic vaginitis diagnosed based on present :
  • Vaginal dischareg ;
  • pH \> 4.5;
  • Donders score≥3;

Exclusion Criteria6

  • Patients with other vaginitis, cervical erosion, or suspected gonorrhea, herpes simplex virus infection and other vulvar diseases;
  • Patients received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission.
  • Pregnancy, lactation and intentional pregnancy;
  • Women with liver and kidney dysfunction, low immune function, diabetes, psychosis or other serious diseases;
  • Allergic constitution and patients allergic to drug ingredients in this study;
  • Those with poor compliance.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGExperimental: Baofukang Suppository 7 days

Experimental: Baofukang Suppository 7 days

DRUGExperimental: Baofukang Suppository 14 days

Experimental: Baofukang Suppository 14 days


Locations(1)

Peking University Shenzhen Hosptal

Shenzhen, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04574089


Related Trials